Supplementary Figures from Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
Yige Wu, Siqi Chen, Xiaolu Yang, Kazuhito Sato, Preet Lal, Yuefan Wang, Andrew Shinkle, Michael C. Wendl, Tina Primeau, Yanyan Zhao, Alanna Gould, Hua Sun, Jacqueline L. Mudd, Jeremy Hoog, R. Jay Mashl, Matthew A. Wyczalkowski, Chia-Kuei Mo, Ruiyang Liu, John M. Herndon, Sherri R. Davies, Di Liu, Xi Ding, Yvonne A. Evrard, Bryan E. Welm, David H. Lum, Mei Yee Koh, Alana L. Welm, Jeffrey H. Chuang, Jeffrey A. Moscow, Funda Meric‐Bernstam, Ramaswamy Govindan, Shunqiang Li, James J. Hsieh, Ryan C. Fields, Kian‐Huat Lim, X. Cynthia, Hui Zhang, Li Ding, Feng Chen
Cited by 0Open Access
Abstract
<p>Supplementary Figure S1-5</p>
Related Papers
No related papers found
Powered by citation graph analysis